breath holding. Other and unspecified abnormalities of breathing
Conditions
Interventions
Intervention 1: Control group: 40 mg/kg piracetam single dose daily. Intervention 2: Intervention group: 40 mg/kg Piracetam in two doses every 12 hours.
Treatment - Drugs
Control group: 40 mg/kg piracetam single dose daily
Intervention group: 40 mg/kg Piracetam in two doses every 12 hours
Sponsors
Vice Chancellor for research of Isfahan University of Medical Sciences
Eligibility
Sex/Gender
All
Age
6 Months to 3 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria for the study included as follows: Age of 6 months to three years; Frequent seizures, more than two times a week; Severe seizures that lead to loss of consciousness Exclusion criteria included as follows: History of seizures; History of heart disease; Anemia (hemoglobin less than 10.5)
Exclusion criteria
Exclusion criteria:
Design outcomes
Secondary
| Measure | Time frame |
|---|---|
| Drug side effects. Timepoint: once in any month for 4 months. Method of measurement: examamination and ask from mother. | — |
Primary
| Measure | Time frame |
|---|---|
| Number of breath holding. Timepoint: once in any month for 4 months. Method of measurement: ask from mother. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr. Akbar Azimi
Isfahan University of Medical Sciences
Outcome results
None listed